- Home
- HGBL vs CTOR Comparison
HGBL vs CTOR Comparison
Compare HGBL & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HGBL
- CTOR
- Stock Information
- Founded
- HGBL 1937
- CTOR 2021
- Country
- HGBL United States
- CTOR United States
- Employees
- HGBL N/A
- CTOR N/A
- Industry
- HGBL Business Services
- CTOR
- Sector
- HGBL Consumer Discretionary
- CTOR
- Exchange
- HGBL Nasdaq
- CTOR NYSE
- Market Cap
- HGBL 81.0M
- CTOR 89.9M
- IPO Year
- HGBL N/A
- CTOR N/A
- Fundamental
- Price
- HGBL $2.03
- CTOR $1.17
- Analyst Decision
- HGBL
- CTOR Strong Buy
- Analyst Count
- HGBL 0
- CTOR 2
- Target Price
- HGBL N/A
- CTOR $4.50
- AVG Volume (30 Days)
- HGBL 51.8K
- CTOR 61.5K
- Earning Date
- HGBL 03-13-2025
- CTOR 02-14-2025
- Dividend Yield
- HGBL N/A
- CTOR N/A
- EPS Growth
- HGBL N/A
- CTOR N/A
- EPS
- HGBL 0.27
- CTOR N/A
- Revenue
- HGBL $49,878,000.00
- CTOR N/A
- Revenue This Year
- HGBL N/A
- CTOR N/A
- Revenue Next Year
- HGBL $19.47
- CTOR N/A
- P/E Ratio
- HGBL $7.50
- CTOR N/A
- Revenue Growth
- HGBL N/A
- CTOR N/A
- 52 Week Low
- HGBL $1.52
- CTOR $0.85
- 52 Week High
- HGBL $3.09
- CTOR $49.00
- Technical
- Relative Strength Index (RSI)
- HGBL 41.96
- CTOR N/A
- Support Level
- HGBL $2.20
- CTOR N/A
- Resistance Level
- HGBL $2.32
- CTOR N/A
- Average True Range (ATR)
- HGBL 0.09
- CTOR 0.00
- MACD
- HGBL -0.03
- CTOR 0.00
- Stochastic Oscillator
- HGBL 37.50
- CTOR 0.00
About HGBL Heritage Global Inc.
Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a global full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.